BSE See NSE See 48,732.55
41.75 (0.09%)
Recommendation From Miscellaneous & Dyes and Pigments Sectors

Recommendation From Miscellaneous & Dyes and Pigments Sectors


The scrips in this column have been recommended with a 15-day investment horizon in mind and carry high risk. Therefore, investors are advised to take into account their risk appetite before investing, as fundamentals may or may not back the recommendations.


CMP -Rs.2333.15
BSE CODE 532777
Volume 33,823
Face ValueRs.10

Info Edge (India) Ltd is a leading provider of various portals related to online recruitment, matrimonial, real estate and education classifieds and related services in India. On the consolidated financial front, the company posted a healthy balance sheet in Q1FY20 with revenues growing 15.39 per cent YoY toRs.319.73 crore. The PBIDT grew by 22.02 per cent YoY toRs.89.19 crore in Q1FY20. The PAT, however, fell 9 per cent toRs.62.41 crore in comparison withRs.69.07 crore posted in Q1FY19. The company has recently entered into an agreement to invest aboutRs.35 crore in Greytip Software. As part of the company's strategic investments, this investment would help the company to diversify its presence into new line of business. The stock of Info Edge has been gaining consecutively since Oct 1, 2019. Looking at the abovementioned factors we recommend a BUY


CMP -Rs.374.65 
BSE CODE 506655
Volume 21,125
Face ValueRs.2


Sudarshan Chemical Industries is a manufacturer of colour and effect pigments. Its pigments segment is involved in manufacturing of Azos, blue and green, high performance pigments, effects, pigment preparations and inorganics. The agro-chemical segment includes generic products. For Q1FY20, net sales reported by the company wereRs.390.26 crore, a growth of 9.96 per cent compared to the sales ofRs.354.90 crore for Q1FY19. The PBDT decreased by 35.14 per cent toRs.81.54 crore in Q1FY20 as againstRs.125.72 crore for Q1FY19. Compared to the net profit ofRs.42.71 crore in Q1FY20, it is 36.03 per cent lower atRs.66.76 crore for Q1FY19. On the annual front, the company has recorded a 9.42 per cent YoY increase in revenue atRs.1453.15 crore for FY19. The PBDT for FY19 and FY18 isRs.273.60 crore andRs.173.02 crore, respectively. The net profit for FY19 wasRs.139.74 crore, a growth of 81.67 per cent compared to the net profit ofRs.76.92 crore in FY18. We recommend a BUY

(Closing price as of Oct 07, 2019)

Comments are only visible to subscribers.

DSIJ Mindshare

Welspun India targets US markets with Target Corporation, board approves buyback & much more!

Geyatee Deshpande / Article rating: 4.5

In a press release, Welspun India stated that the company is set to work with Target Corporation in the USA to achieve business growth. Reacting to the announcements made post the meeting held of its board of directors, its stock jumped by more than 11 per cent. 

Alembic Pharmaceuticals plunge despite getting USFDA nod for Lurasidone Hydrochloride tablets

Shruti Dahiwal / Article rating: 3.7

Alembic Pharmaceuticals Limited, a leading pharmaceutical company, announced today that it has received approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Lurasidone Hydrochloride tablets (20 mg, 40 mg, 60 mg, 80 mg, and 120 mg).